SOX2 has been reported to play a pivotal role in developing drug resistance of glioma (11, 38) and its expression was correlated with the grade of malignancy and favored the maintenance of an undifferentiated state of cancer stem cells (39, 40). The gene discussed is SOX2; the disease is cancer.